Katy Moore

Katy Moore, PharmD, RPh, is a seasoned expert in clinical pharmacology with a robust background in drug development, risk management, and strategic leadership. Currently serving as President of Clinical Pharmacology Modeling and Simulation at Allucent since June 2022, Katy is responsible for business growth, strategy, and management of the CPMS business unit. Previously, as Global Head of Clinical Pharmacology at ViiV Healthcare from September 2015 to May 2022, Katy provided strategic oversight to ensure efficient drug development and commercialization of the portfolio. Katy's extensive experience at GSK spanned from August 1996 to September 2015, holding senior director roles in various capacities that involved multidisciplinary team leadership and technical support in drug discovery. Educational achievements include a Doctor of Pharmacy (PharmD) from the University of North Carolina at Chapel Hill and a Post-Doctoral Fellowship in Clinical Pharmacology from the same institution.